Serum S-100 has prognostic significance in malignant melanoma
Bonfrer, J.M.; Korse, C.M.; Israels, S.P.
Anticancer Research 17(4b): 2975-2977
1997
ISSN/ISBN: 0250-7005 PMID: 9329579 Document Number: 483017
Background: Pretreatment serum values of S-100 and NSE were compared in patients with malignant melanoma. Materials and Methods: Pretreatment serum levels of patients with malignant melanoma were analysed for stage of disease and survival. Results: S-100 pretreatment serum values seem highly specific, but have low sensitivity. Conclusion: Further evaluation is needed with an assay with improved sensitivity.